Primary hyperparathyroidism and malignancy: Forgotten friends or new aquaintances.
作者信息
Chatterjee Krishnarpan, Sen Chetana, Ghosh Gopal C
机构信息
Department of Medicine, Dr. Ram Manohar Lohia Hospital, New Delhi, India.
Department of Medicine, Medical College, Kolkata, West Bengal, India.
出版信息
Indian J Endocrinol Metab. 2014 May;18(3):436. doi: 10.4103/2230-8210.131232.
Abstract
摘要
相似文献
1
Primary hyperparathyroidism and malignancy: Forgotten friends or new aquaintances.原发性甲状旁腺功能亢进症与恶性肿瘤：被遗忘的关联还是新发现的关系
Indian J Endocrinol Metab. 2014 May;18(3):436. doi: 10.4103/2230-8210.131232.
2
Osteitis fibrosa cystica-a forgotten radiological feature of primary hyperparathyroidism.囊性纤维性骨炎——原发性甲状旁腺功能亢进症被遗忘的放射学特征。
Endocrine. 2017 Nov;58(2):380-385. doi: 10.1007/s12020-017-1414-2. Epub 2017 Sep 12.
3
Primary hyperparathyroidism-jaw tumor syndrome: a confusing and forgotten diagnosis.原发性甲状旁腺功能亢进-颌骨肿瘤综合征：一种容易混淆且被遗忘的诊断。
Clujul Med. 2016;89(4):555-558. doi: 10.15386/cjmed-638. Epub 2016 Oct 20.
4
Osteitis fibrosa cystica simulating metastatic tumor. An almost-forgotten relationship.模拟转移性肿瘤的纤维囊性骨炎。一种几乎被遗忘的关系。
Am J Clin Pathol. 1993 Dec;100(6):697-700. doi: 10.1093/ajcp/100.6.697.
5
Multifactorial hypercalcemia and literature review on primary hyperparathyroidism associated with lymphoma.多因素性高钙血症及原发性甲状旁腺功能亢进症合并淋巴瘤的文献综述
Case Rep Endocrinol. 2014;2014:893134. doi: 10.1155/2014/893134. Epub 2014 Mar 5.
6
Serum calcium (S-Ca), the forgotten test: preliminary results of an appropriateness strategy to detect primary hyperparathyroidism (pHPT).血清钙（S-Ca），被遗忘的检测：一项旨在检测原发性甲状旁腺功能亢进症（pHPT）的适宜性策略的初步结果。
Bone. 2013 Sep;56(1):73-6. doi: 10.1016/j.bone.2013.05.011. Epub 2013 May 23.
7
[Forgotten physician-friends of Frederic Chopin].[被遗忘的弗雷德里克·肖邦的医生朋友们]
Pol Tyg Lek (Wars). 1956 Jun 11;11(24):1102-4.
8
Association of primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with clear cell renal carcinoma.一名肾透明细胞癌患者原发性甲状旁腺功能亢进与恶性肿瘤体液性高钙血症的关联
Arch Endocrinol Metab. 2015 Feb;59(1):84-8. doi: 10.1590/2359-3997000000015.
9
Primary hyperparathyroidism and malignancy: "studies by nature".原发性甲状旁腺功能亢进症与恶性肿瘤：“基于性质的研究”
Bone. 2006 Aug;39(2):420-3. doi: 10.1016/j.bone.2006.01.146. Epub 2006 Mar 10.
10
On the etiology of "primary" hyperparathyroidism.关于“原发性”甲状旁腺功能亢进症的病因
Am Surg. 1976 Aug;42(8):541-6.
本文引用的文献
1
Primary hyperparathyroidism in a case of chronic myelogenous leukemia.慢性粒细胞白血病患者的原发性甲状旁腺功能亢进症。
Indian J Endocrinol Metab. 2013 Sep;17(5):942-3. doi: 10.4103/2230-8210.117201.
2
The association between primary hyperparathyroidism and malignancy: nationwide cohort analysis on cancer incidence after parathyroidectomy.原发性甲状旁腺功能亢进与恶性肿瘤之间的关联：甲状旁腺切除术后癌症发病率的全国性队列分析。
Endocr Relat Cancer. 2007 Mar;14(1):135-40. doi: 10.1677/erc.1.01261.
3
The epidemiology of vitamin D and cancer incidence and mortality: a review (United States).维生素D与癌症发病率和死亡率的流行病学：综述（美国）
Cancer Causes Control. 2005 Mar;16(2):83-95. doi: 10.1007/s10552-004-1661-4.
4
HYPERPARATHYROIDISM AND CANCER.甲状旁腺功能亢进与癌症
Br Med J. 1964 Jul 25;2(5403):218-21. doi: 10.1136/bmj.2.5403.214-a.
5
Increased risk of malignant diseases after surgery for primary hyperparathyroidism. A nationwide cohort study.
Am J Epidemiol. 1988 May;127(5):1031-40. doi: 10.1093/oxfordjournals.aje.a114879.
6
Primary hyperparathyroidism and chronic lymphocytic leukemia.原发性甲状旁腺功能亢进症与慢性淋巴细胞白血病。
Cancer. 1978 Oct;42(4):1964-9. doi: 10.1002/1097-0142(197810)42:4<1964::aid-cncr2820420440>3.0.co;2-#.
Zotero 插件